Pembrolizumab,Cisplatin,Gemcitabine,Pemetrexed
Merck
['keytruda', 'nsclc', 'sclc']
asco 2023: keytruda becomes a new option in perioperative nsclc #asco23 #nsclc
A digital magazine bringing you the latest trends and technologies in the industry. With daily news from Pharmaceutical Technology https://t.co/158ZeZ0UND